In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 2, 1999, Pages 291-294

  Bergeret, M ^a   Raymond, J ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAMANDOLE; CEFPIROME; GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DRUG POTENTIATION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; CEFAMANDOLE; CEPHALOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SERUM BACTERICIDAL TEST; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 0033003158     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.2.291     Document Type: Article

References (10)

1. Debbia, E., Pesce, A. & Schito, G. C. (1986). In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. Journal of Hospital Infection 7, Suppl. A, 73-7.
2. Barr, J. G., Smyth, E. T. M. & Hogg, G. M. (1990). In vitro antimicrobial activity of imipenem in combination with vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. European Journal of Clinical Microbiology and Infectious Diseases 9, 804-9.
3. Seibert, G., Isert, D., Kiesel, N., Limbert, M., Markus, A. & Schrinner, E. (1992). The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 29, Suppl. A, 25-30.
4. Raymond, J., Vedel, G. & Bergeret, M. (1996). In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci. Journal of Antimicrobial Chemotherapy 38, 1067-71.
5. Stratton, C. W., Liu, C. & Weeks, L. S. (1987). Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrobial Agents and Chemotherapy 31, 1210-5.
6. Vedel, G., Bouchet, E., Gangneux, J. P. & Nevot, P. (1996). A simple micro-method for time-kill studies amenable to routine laboratory use. Journal of Antimicrobial Chemotherapy 37, 842-4.
7. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents: Tentative Guideline M26-T. NCCLS, Villanova, PA.
8. Chang, S. C., Hsieh, W. C., Luh, K. T. & Ho, S. W. (1989). Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro. Taiwan I Hsueh Hui Tsa Chih [Journal of the Formosan Medical Association] 88, 488-92.
9. Drugeon, H. B., Caillon, J., Juvin, M. E. & Picault, J. L. (1991). Bactericidal activity of cefpirome-fosfomycin in comparison with cefotaxime-fosfomycin against Staphylococcus aureus. In Abstracts of the Seventeenth International Congress of Chemotherapy, Berlin, 23-28 June 1991. Futuramed, Munich. Abstract 256.
10. Sieradzki, K. & Tomasz, A. (1997). Suppression of β-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. Journal of Antimicrobial Chemotherapy 39, Suppl. A, 47-51